Bar Plot from Scientific Research

Quantification of relative growth of DMSO vehicle control, olaparib (50 mg/kg), palbociclib (40 mg/kg), and combination olaparib + ceralasertib treated EGFP;MYCN;tp53−/−;brca2+/–NB. Combined results from two independent primary tumors, minimum two technical replicates for each treatment cohort. Differences between control and combination treatment group is significant (p= 0.0037), Student’s t test.

DOI